News
Events
Overview
Rationale for Immunodrugs™
Strategy
Board & Management
Industry Collaborations
Letter of the CEO
History
Overview
Immunodrug™ Platform
Immunodrug™ Manufacturing
Scientific Collaborations
Scientific Publications
Pipeline
Clinical Trials
Disease Areas
Overview
Board & Management
Share Information
Bond Information
Analyst Coverage
Financial Calendar
Financial Reports
Corporate Governance
Stay Informed
Contact
Overview
Press Release Archive
Downloads
Picture Gallery
Contact
Analyst
Coverage
Cytos
Press Releases
 
Cytos
Facts & Figures
 
Cytos Biotechnology AG
Wagistrasse 25
Postfach
8952 Schlieren
Switzerland
T +41 44 733 47 47
F +41 44 733 47 40
e-mail contact

Cytos Biotechnology is currently followed by the analysts shown below; this list may not be complete and is subject to change as the analysts' firms initiate or cease coverage of Cytos Biotechnology. Cytos Biotechnology is providing this list as a service to its shareholders and not as an endorsement or adoption of or concurrence with the information, conclusions or recommendations provided by these analysts. Any opinions, estimates or forecasts regarding Cytos Biotechnology's historical or predicted performance made by these analysts and their firms are theirs alone and do not represent opinions, forecasts or predictions of Cytos Biotechnology or its management.

 
  Analyst Contact
line
  Bank am Bellevue AG Bruno Eschli

+41 44 267 72 85
bes@bellevue.ch

line
  Bank Vontobel
 
Andrew Weiss +41 58 283 71 52
andrew.weiss@vontobel.ch
line
  IXIS Securities
 
Philippe Lanone +33 1 58 55 05 03
planone@ixis-sec.com
line